ATNM vs KEYS · rev $35.0M vs P/E 57, rev $5.16B
Actinium Pharmaceuticals Inc (ATNM) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
ATNM currently screens at market cap $33.9M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the ATNM and KEYS stock pages for the full models.
Not investment advice.